Skip to main content
. 2017 Aug 17;16(4):5393–5405. doi: 10.3892/mmr.2017.7275

Figure 2.

Figure 2.

Expression of miR-136-5p in various clinicopathological factors of hepatocellular carcinoma using the reverse transcription-quantitative polymerase chain reaction. (A) Metastasis; (B) TNM stage; (C) portal vein tumor embolus and; (D) vaso-invasion. miR, microRNA.